ABCSG 18 Summary
Randomized, doubleblind, placebo-controlled, multi-center phase-3-study to determine the treatment effect of denosumab in subjects with non-metastatic breast cancer receiving non-steroidal aromatase inhibitor therapy.
|Coordinating investigator:||Gnant, Michael; Vienna|
(Click to enlarge)
Link for studyteam-members only
Further information about this trial
Access to these informations only with keyword. If required, please ask the responsible project manager.